Cambridge Crystallographic Data Centre as supplementary
publication nos. CCDC 1884802. Copies of the data can be
obtained, free of charge, on application to CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-336033 or e-
mail: deposit@ccdc.cam.ac.Uk).
References and notes
1.
Smith, L. K.; Baxendale, I. R., Org. Biomol. Chem. 2015, 9907–
9933.
2.
3.
Zhou, Q. L.; Xie, J. H., Top Organomet. Chem. 2011, 36, 1–28.
Zheng, Y.; Tice, C. M.; Singh, S. B., Bioorg. Med. Chem. Lett.
2014, 24, 3673–3682.
4.
Saragi, R. P. I.; Spehr, T.; Siebert, A.; Fuhrmann-Lieker, T.;
Salbeck, J., Chem. Rev. 2007, 107, 1011–1065.
Krattenmacher, R., Contreception 2000, 62, 29–38.
Bartoli, A.; Rodier, F.; Commeiras, L.; Parrain, J.-L.; Chouraqui,
G., Nat. Prod. Rep. 2011, 28, 763–782.
Figure 2. 1H NMR experiment.
5.
6.
3. Conclusion
7.
Zhang, W.-J.; Li, X.-H.; Shi, Y.-P., J. Nat. Prod. 2010, 73, 143–
146.
In conclusion, we describe a straightforward method for the
synthesis of novel enantioenriched all-carbon spirocycles.
Formation of the first lactone ring via an asymmetric Brønsted
acid catalyzed desymmetrization of dialkylated diesters is
followed by a second cyclization utilizing a general acid. This
method offers access to new scaffolds that are likely find use in
future applications.
8.
9.
Wu, Z.-X.; Shi, Y.-P.; Yang, L., Org. Lett. 2004, 6, 2313–2316.
Karawajczyk, A.; Giordanetto, F.; Benningshof, J.; Hamza, D.;
Kalliokoski, T.; Pouwer, K.; Morgentin, R.; Nelson, A.; Müller,
G.; Piechot, A.; Tzalis, D., Drug Discovery Today 2015, 20,
1310–1316.
10. Wilent, J. E.; Qabaja, G.; Petersen, K. S., Org. Synth. 2016, 93,
75–87.
11. Wilent, J.; Petersen, K. S., J. Org. Chem. 2014, 79, 2303–2307.
12. Changotra, A.; Sunoj, R. B., Org. Lett. 2016, 18, 3730–3733.
13. Fristad, W. E.; Hershberger, S. S., J. Org. Chem. 1985, 50, 1026–
1031.
Acknowledgments
14. A one pot cyclization of the corresponding diol of 4b was
attempted with 10 mol% TRIP, however only recovered starting
material was obtained.
Financial support is gratefully acknowledged from the
National Institutes of Health (GM116041) and the University of
Asymmetric synthesis of novel spirocycles
via a chiral phosphoric acid catalyzed
desymmetrization
Leave this area blank for abstract info.
Amber M. Kelley, Eni Minerali, Jennifer E. Wilent, Nicholas J. Chambers, Kyla J. Stingley, G. Tyler Wilson,
and Kimberly S. Petersen*
O
O
O
O
O
1. deprotection
TRIP
1. deprotection
2. cyclization
O
n
O
O
O
O
X
2. (R)-
(10 mol%)
n
PG2X
O
n
OPG1
PG2X
readily available
from
di-tert-butyl malonate
Desymmetrization
1st cyclization sets
stereocenter
Enantioenriched spirocycle
2nd cyclization preserves
stereocenter
15. Crystallographic data (excluding structure factors) for the
structures in this paper have been deposited with the Cambridge
Crystallographic Data Centre as supplementary publication nos.
CCDC 1884802. Copies of the data can be obtained, free of
charge, on application to CCDC, 12 Union Road, Cambridge CB2
1EZ, UK, (fax: +44-(0)1223-336033 or e-mail:
North Carolina at Greensboro. Additionally, we thank Dr.
Franklin J. Moy and Dr. Daniel Todd for assistance with NMR
and mass spectrometry data analysis. All X-ray crystallography
measurements were made in the Molecular Education,
Technology, and Research Innovation Center (METRIC) at NC
State University and we wish to thank Roger Sommer for his
assistance. Research reported in this publication was supported in
part by the National Center for Complementary and Integrative
Health of the National Institutes of Health under award number 5
T32 AT008938. This work was performed in part at the Joint
School of Nanoscience and Nanoengineering, a member of the
Southeastern Nanotechnology Infrastructure Corridor (SENIC)
and National Nanotechnology Coordinated Infrastructure
(NNCI), which is supported by the National Science Foundation
(Grant ECCS-1542174).
deposit@ccdc.cam.ac.Uk).
16. Compound 5b (21 mg, 0.085 mmol) and TsOH (49 mg, 0.25
mmol) in 5.9 mL of a 0.1 M stock solution of 1,2,4,5-tetrachloro-
3-nitrobenzene. See SI for more details.
Graphical Abstract
To create your abstract, type over the instructions in the
template box below.
Fonts or abstract dimensions should not be changed or altered.
Supplementary Material
Formation of novel enantioenriched
spirolactones
Supplementary data for this work can be found online at
https://xxxx. Crystallographic data (excluding structure factors)
for the structures in this paper have been deposited with the